Autopsy report · NCT03287947

LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.

“Low enrollment”

The sponsor’s own words in the registry.

Life of this trial

Registered 3 months before it started.
Ran for about 2 years before it stopped.
5 participants enrolled.
Results were posted on the registry 1 year 8 months after it ended.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Wake Forest University Health Sciences
Sponsor type: University, hospital or other
Conditions: Appendix Cancer
Interventions: nintedanib
Participants: 5
Sites: 1
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.